Emergent BioSolutions (EBS) Revenue & Revenue Breakdown
Emergent BioSolutions Revenue Highlights
Latest Revenue (Y)
$1.05B
Latest Revenue (Q)
$254.70M
Main Segment (Y)
Product
Main Geography (Y)
Services Segment
Emergent BioSolutions Revenue by Period
Emergent BioSolutions Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $1.05B | -6.39% |
2022-12-31 | $1.12B | -37.47% |
2021-12-31 | $1.79B | 15.26% |
2020-12-31 | $1.56B | 40.63% |
2019-12-31 | $1.11B | 41.36% |
2018-12-31 | $782.40M | 39.50% |
2017-12-31 | $560.87M | 14.75% |
2016-12-31 | $488.78M | -6.50% |
2015-12-31 | $522.79M | 16.14% |
2014-12-31 | $450.14M | 43.93% |
2013-12-31 | $312.75M | 10.95% |
2012-12-31 | $281.89M | 3.11% |
2011-12-31 | $273.38M | -4.47% |
2010-12-31 | $286.17M | 21.89% |
2009-12-31 | $234.79M | 31.49% |
2008-12-31 | $178.55M | -2.38% |
2007-12-31 | $182.91M | 19.76% |
2006-12-31 | $152.73M | 16.87% |
2005-12-31 | $130.69M | 56.52% |
2004-12-31 | $83.49M | 49.71% |
2003-12-31 | $55.77M | -28.99% |
2002-12-31 | $78.54M | 73.35% |
2001-12-31 | $45.31M | - |
Emergent BioSolutions Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | $254.70M | -15.21% |
2024-03-31 | $300.40M | 8.60% |
2023-12-31 | $276.60M | 2.26% |
2023-09-30 | $270.50M | -19.95% |
2023-06-30 | $337.90M | 104.66% |
2023-03-31 | $165.10M | -50.08% |
2022-12-31 | $330.70M | 37.79% |
2022-09-30 | $240.00M | -1.11% |
2022-06-30 | $242.70M | -21.07% |
2022-03-31 | $307.50M | -57.48% |
2021-12-31 | $723.20M | 119.82% |
2021-09-30 | $329.00M | -17.23% |
2021-06-30 | $397.50M | 15.89% |
2021-03-31 | $343.00M | -41.17% |
2020-12-31 | $583.00M | 51.35% |
2020-09-30 | $385.20M | -2.41% |
2020-06-30 | $394.70M | 105.04% |
2020-03-31 | $192.50M | -46.59% |
2019-12-31 | $360.40M | 15.59% |
2019-09-30 | $311.80M | 28.21% |
2019-06-30 | $243.20M | 27.60% |
2019-03-31 | $190.60M | -29.59% |
2018-12-31 | $270.70M | 55.89% |
2018-09-30 | $173.65M | -21.14% |
2018-06-30 | $220.20M | 86.90% |
2018-03-31 | $117.81M | -39.21% |
2017-12-31 | $193.81M | 29.70% |
2017-09-30 | $149.43M | 48.29% |
2017-06-30 | $100.77M | -13.77% |
2017-03-31 | $116.86M | -22.95% |
2016-12-31 | $151.66M | 6.12% |
2016-09-30 | $142.91M | 40.82% |
2016-06-30 | $101.49M | -8.57% |
2016-03-31 | $111.00M | -33.97% |
2015-12-31 | $168.10M | 1.92% |
2015-09-30 | $164.94M | 30.79% |
2015-06-30 | $126.11M | 98.19% |
2015-03-31 | $63.63M | -57.00% |
2014-12-31 | $147.97M | 7.26% |
2014-09-30 | $137.95M | 25.04% |
2014-06-30 | $110.33M | 104.75% |
2014-03-31 | $53.88M | -45.08% |
2013-12-31 | $98.11M | 10.11% |
2013-09-30 | $89.10M | 8.09% |
2013-06-30 | $82.44M | 91.27% |
2013-03-31 | $43.10M | -54.44% |
2012-12-31 | $94.61M | 42.07% |
2012-09-30 | $66.59M | -5.38% |
2012-06-30 | $70.38M | 39.89% |
2012-03-31 | $50.31M | -53.39% |
2011-12-31 | $107.95M | 83.70% |
2011-09-30 | $58.76M | -33.33% |
2011-06-30 | $88.14M | 375.59% |
2011-03-31 | $18.53M | -82.05% |
2010-12-31 | $103.25M | 39.55% |
2010-09-30 | $73.99M | 19.07% |
2010-06-30 | $62.14M | 32.77% |
2010-03-31 | $46.80M | -13.02% |
2009-12-31 | $53.80M | 24.34% |
2009-09-30 | $43.27M | -40.88% |
2009-06-30 | $73.19M | 13.44% |
2009-03-31 | $64.52M | 80.47% |
2008-12-31 | $35.75M | -36.84% |
2008-09-30 | $56.60M | 30.16% |
2008-06-30 | $43.48M | 1.79% |
2008-03-31 | $42.72M | -52.34% |
2007-12-31 | $89.64M | - |
Emergent BioSolutions Revenue Breakdown
Emergent BioSolutions Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
Commercial Product | $497.30M | - | - | - | - |
Product | $944.50M | $966.20M | - | - | - |
Contracts and Grants | $26.30M | $41.40M | $71.30M | - | - |
Service | $72.80M | - | - | - | - |
Contract Development And Manufacturing | - | $113.30M | $450.50M | $80.00M | - |
Contract Development And Manufacturing, Leases | - | - | $108.00M | - | - |
Contracted Operating Leases | - | - | - | $165.30M | - |
Latest
Quarterly Revenue by Product
Product/Service | Sep 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | Mar 21 | Sep 20 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Contracts and Grants | $10.00M | $6.70M | $6.50M | $6.60M | $6.50M | $7.10M | $17.40M | $7.30M | $9.60M | - | - | - | - |
Service | $13.90M | $59.60M | $13.20M | - | - | $17.70M | - | - | - | - | - | - | - |
Product | $269.50M | $249.10M | $249.80M | $302.20M | $143.40M | $305.70M | - | - | - | - | - | - | - |
Commercial Product | $95.30M | - | - | - | - | - | - | - | - | - | - | - | - |
Contract Development And Manufacturing | - | - | $14.20M | $29.10M | $15.20M | $17.90M | - | - | - | - | - | - | - |
Contract Development And Manufacturing, Leases | - | - | - | - | - | - | $200.00K | $400.00K | $104.20M | $114.60M | - | - | - |
Contracted Operating Leases | - | - | - | - | - | - | - | - | - | - | $129.70M | $146.60M | $177.70M |
Latest
Emergent BioSolutions Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
Services Segment | $78.50M | - | - | - | - |
CANADA | - | $148.60M | - | - | - |
UNITED STATES | - | $889.50M | $897.80M | $626.00M | $568.80M |
Other Geographical Area | - | $82.80M | - | - | - |
Non-US | - | - | $894.90M | $363.80M | $334.70M |
Latest
Quarterly Revenue by Country
Country | Sep 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Services Segment | $14.30M | $20.00M | $14.20M | $29.10M | $15.20M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
UNITED STATES | - | - | - | - | - | $602.80M | $49.80M | $124.40M | $112.50M | $502.60M | $60.20M | $66.30M | $56.40M | $235.50M | $102.40M | $224.20M | $63.90M | $230.70M | $170.20M | $94.60M |
Non-US | - | - | - | - | - | - | $190.20M | $118.30M | $195.00M | $220.60M | $268.80M | $114.90M | $81.50M | $105.40M | $99.80M | $74.30M | $84.30M | $80.10M | $86.00M | $88.90M |
Latest
Emergent BioSolutions Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
BHC | Bausch Health Companies | $8.76B | $2.51B |
ZTS | Zoetis | $8.54B | $2.39B |
NBIX | Neurocrine Biosciences | $1.89B | $622.10M |
ALKS | Alkermes | $1.66B | $378.14M |
PBH | Prestige Consumer Healthcare | $1.13B | $283.55M |
EBS | Emergent BioSolutions | $1.05B | $254.70M |
COLL | Collegium Pharmaceutical | $566.77M | $159.30M |
ITCI | Intra-Cellular Therapies | $462.18M | $175.38M |
DCPH | Deciphera Pharmaceuticals | $163.36M | $45.00M |
LFCR | Lifecore Biomedical | $128.26M | $24.70M |
CPIX | Cumberland Pharmaceuticals | $39.55M | $9.09M |
DRRX | DURECT | $8.55M | $1.56M |
AKAN | Akanda | $2.16M | $762.61K |
PETQ | PetIQ | $1.10M | $328.94M |